Your Messages Inbox
Your Article Summary
See Latest ArticlesFDA Issues Early Communication About Ongoing Safety Review of Weight Loss Drug Orlistat
Gastroenterology, 10/27/09
The US Food and Drug Administration (FDA) announced that it is reviewing new safety information regarding reports of liver–related adverse events in patients taking orlistat. Orlistat is marketed in the United States as a prescription product, Xenical, and as an over–the–counter (OTC) product, Alli.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Article Search
Sponsor